• Publications
  • Influence
Clinical Guideline: Management of Gastroparesis
Current approved treatment options, including metoclopramide and gastric electrical stimulation (GES), do not adequately address clinical need and attention should be given to the development of new effective therapies for symptomatic control. Expand
Gastric electrical stimulation for medically refractory gastroparesis.
High-frequency/low-energy gastric electrical stimulation significantly decreased vomiting frequency and gastrointestinal symptoms and improved quality of life in patients with severe gastroparesis. Expand
Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine
This consensus statement from the members of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine recommends a standardized method for measuring gastricExpand
Assessment of gastric emptying using a low fat meal: establishment of international control values
Gastric retention of >10% at 4 h is indicative of delayed emptying, a value comparable to those provided by more intensive scanning approaches, and gastric emptying values defined in healthy subjects are provided. Expand
Cyclic vomiting syndrome in adults
This article is a state‐of‐knowledge overview on CVS in adults and is intended to provide a framework for management and further investigations into CVD in adults. Expand
Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities.
Irritable bowel syndrome specific-symptom subgroups had different patterns of autonomic functioning, colonic transit, and psychological measures; the constipation subgroup showed more psychological distress. Expand
Gastric Electrical Stimulation in Intractable Symptomatic Gastroparesis
Electrical stimulation of the stomach has an immediate and potent anti-emetic effect and offers a safe and effective alternative for patients with intractable symptomatic gastroparesis in a non-placebo-controlled study. Expand
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting
The aetiology and pathophysiology of gastroparesis and functional dyspepsia remain incompletely understood and the diagnostic and treatment options for these two disorders are relatively limited. Expand
Abnormal initiation and conduction of slow-wave activity in gastroparesis, defined by high-resolution electrical mapping.
High-resolution mapping revealed new categories of abnormal human slow-wave activity that could contribute to the pathogenesis of gastroparesis, including aberrant initiation, aberrant conduction, and low amplitude activity. Expand
Treatment of gastroparesis: a multidisciplinary clinical review
To provide practical guidelines for treatment, this document covers results of published research studies in the literature and areas developed by consensus agreement where clinical research trials remain lacking in the field of gastroparesis. Expand